(Reuters) – Vaccine maker Seqirus, a part of Australia-based biotech company CSL ltd, said on Tuesday it has started shipping its influenza vaccines to the United States and can supply about 60 million doses of its shots for the upcoming flu season. The company, one of the largest vaccine providers in the world, is ramping […]